DOH: Sinopharm jab recipients OK’d to get booster shots

By Alec Go

The Department of Health (DOH) announced that individuals who were administered Sinopharm COVID-19 vaccines in their primary dose series will be eligible to receive booster shots.

According to the DOH, the vaccines of Sinopharm, AstraZeneca, Pfizer-BioNTech, and Moderna can be used as booster dose for Sinopharm recipients.

In the Jan. 28 Palace briefing, Health Undersecretary Maria Rosario Vergeire said an emergency use authorization has been issued by the Food and Drug Administration, together with the guidance from the National Vaccination Operations Center.

The DOH also approved the use of Gamaleya’s Sputnik Light vaccine in the country’s COVID-19 booster administration.

Screenshot of DOH report in the Jan. 28, 2022 Palace briefing. / PTV

“Ang eligible pa lamang sa ating booster shots ay ang mga 18 years-old at pataas. Amin din po nililinaw na ang mga nabanggit na booster doses ay nakadepende pa rin sa available vaccines,” she said.

“Nais pong bigyang diin ng DOH na hindi puwedeng i-booster sa mga buntis at mga nagpapasuong ina ang Sinopharm at Gamaleya Sputnik,” she added.

Based on the agency’s infographic, Sputnik Light may be used as a booster for those who have received AstraZeneca, Moderna, Pfizer, and Sinovac jabs in their primary series.

Popular

Can an arrest warrant be served to a suspect’s lawyer? NBI says no

By Brian Campued A warrant of arrest cannot be served to a suspect’s legal counsel, according to the National Bureau of Investigation (NBI). In a press...

Palace declares May 27 regular holiday for Eid al-Adha

By Brian Campued Malacañang has declared May 27, 2026 a regular holiday in observance of Eid al-Adha or the “Feast of Sacrifice” in Islam. The announcement...

DOJ tasks PNP, NBI to ‘effect the arrest’ of Bato

By Brian Campued “We’re pursuing this so that the ends of justice may be achieved.” The Department of Justice (DOJ) has given the greenlight for law...

PH earns 76/100 transparency score in int’l survey

By Dean Aubrey Caratiquet “These achievements are encouraging. For us in government, these however, are not the destination.” In his keynote speech on Wednesday, Department of...